
Not the moonshot investors wanted
AST SpaceMobile kicked off Tuesday by reminding everyone that satellite telecom dreams still come with very terrestrial headaches. The company reported a Q1 loss of 66 cents per share, which was a lot messier than Wall Street’s expected 23-cent loss, and revenue landed at $14.74 million — nowhere near the $37.63 million analysts were looking for.
The market hit the brakes
That mismatch was enough to send the stock down 11% in pre-market trading to $73.45. When a company is priced like a future platform and then prints a quarter that says “not yet,” traders tend to yank the emergency cord pretty fast.
The ripple effect in pre-market
ASTS wasn’t alone in the penalty box. A bunch of other names were getting smacked around too, including:
- Hims & Hers Health, down after weak Q1 results
- GitLab, after announcing a reduction in force
- Bakkt, Harrow, CleanSpark, Life360, and others, each with their own flavor of disappointing numbers or guidance
Big picture
For ASTS, the takeaway is simple: the story is still about future potential, but the market wants proof now. And when growth stocks miss on both profit and revenue, investors usually don’t stick around to admire the roadmap.
